Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: SINOPHARM(CNCM LTD)(600511) the Revenue is 13.17 B (+1.95%);the EBIT is 505.11 M (+3.1%);the EPS is 0.537 (-17.17%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
13.17B1.95%
----
----
EBIT
0.51B3.10%
----
----
EPS
0.537417.17%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf